<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02046200</url>
  </required_header>
  <id_info>
    <org_study_id>IVM</org_study_id>
    <secondary_id>UL1TR000124</secondary_id>
    <nct_id>NCT02046200</nct_id>
  </id_info>
  <brief_title>Development of Ivermectin for Alcohol Use Disorders</brief_title>
  <official_title>Repositioning Ivermectin for the Treatment of Alcohol Use Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current pharmacotherapies for alcohol use disorders (AUDs) have limited efficacy. Thus, the
      development of effective treatments for AUDs represents an important public health objective.
      Repositioning, i.e. using existing approved drugs for other indications, represents a fast
      and economically feasible approach for drug development. Ivermectin (IVM) is an FDA-approved
      antiparasitic medication that can significantly reduce alcohol intake in mice, suggesting
      that it may be useful in the treatment of AUDs in humans. The goal of this project is to
      provide key clinical evidence that IVM can be repositioned as a novel therapeutic agent to
      treat AUDs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Current pharmacotherapies for alcohol use disorders (AUDs) have limited efficacy. Thus, the
      development of effective treatments for AUDs represents an important public health objective.
      Repositioning, i.e. using existing approved drugs for other indications, represents a fast
      and economically feasible approach for drug development. Ivermectin (IVM) is an FDA-approved
      antiparasitic medication that can significantly reduce alcohol intake in mice, suggesting
      that it may be useful in the treatment of AUDs in humans. The goal of this project is to
      provide key clinical evidence that IVM can be repositioned as a novel therapeutic agent to
      treat AUDs. We will enroll 10 alcohol dependent individuals in a placebo-controlled
      randomized pilot safety trial of IVM (30 mg orally once) over a 2-day (1-night) inpatient
      stay at the UCLA CTRC and employ a well-characterized battery of behavioral paradigms (i.e.,
      alcohol administration and cue exposure). The goals of the study are to test: (a) the safety
      of combining IVM, at a dose currently shown to be safe in humans (30 mg), with moderate doses
      of alcohol (0.08 g/dl); and (b) whether IVM reduces the reinforcing effects of alcohol during
      alcohol administration and whether it reduces alcohol craving during cue exposure, as
      compared to placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Post-medication administration (hours): 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48; During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl</time_frame>
    <description>Heart rate (measured in beats per minute; BPM) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
During the infusion, the times for collecting HR will vary based on how long it takes participants to reach the targeted BrACs.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Post-medication administration (hours): 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48; During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl</time_frame>
    <description>Blood pressure (measured in mmHg) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
Blood pressure is measured at 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48 hours post-medication administration; and during alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl. During the infusion, the times for collecting BP will vary based on how long it takes participants to reach the targeted BrACs.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Post-medication administration (hours): 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48; During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl</time_frame>
    <description>Blood pressure (measured in mmHg) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
Blood pressure is measured at 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48 hours post-medication administration; and during alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl. During the infusion, the times for collecting BP will vary based on how long it takes participants to reach the targeted BrACs.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Alcohol Urge Questionnaire (AUQ)</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Alcohol Urge Questionnaire (AUQ), which consists of 8 items associated with urge to drink alcohol, rated on a 7 point scale (1 = strongly disagree, 7 = strongly agree).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;Feel&quot; Subscale</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Do you feel any drug effects?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;Like&quot; Subscale</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Do you like the effects you are feeling right now?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;More&quot; Subscale</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Would you like more of the drug right now?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;High&quot; Subscale</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Are you high?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Biphasic Alcohol Effects Scale (BAES) - Stimulant Subscale</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Biphasic Alcohol Effects Scale (BAES) , which consists of 14 items designed to capture the stimulant and sedative effects of alcohol, each rated on an 11-point scale (0 = not at all, 10 = extremely). The total score for the Stimulant Subscale ranges from 0 to 70. Mean scores across all subjects are reported below.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Effects of Alcohol Using the Biphasic Alcohol Effects Scale (BAES) - Sedative Subscale</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
    <description>Subjective effects of alcohol will be measured using the Biphasic Alcohol Effects Scale (BAES) , which consists of 14 items designed to capture the stimulant and sedative effects of alcohol, each rated on an 11-point scale (0 = not at all, 10 = extremely). The total score for the Sedative Subscale ranges from 0 to 70. Mean scores across subjects are reported below.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cue-induced Craving Using the Alcohol Urge Questionnaire (AUQ)</measure>
    <time_frame>6 hours post-medication administration</time_frame>
    <description>Cue-induced craving will be measured using the Alcohol Urge Questionnaire (AUQ), which consists of 8 items associated with urge to drink alcohol, rated on a 7 point scale (0 = strongly disagree, 6 = strongly agree). Item scores were averaged and the total score also ranges from 0-6.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Effects</measure>
    <time_frame>During alcohol infusion at BrAC = 0.00, 0.04, 0.08 g/dl</time_frame>
    <description>Adverse effects will be monitored to determine the safe of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl) using the Systematic Assessment for Treatment Emergent Effects (SAFTEE). The SAFTEE is a 24-item checklist in which the participant can identify whether a symptom is present (yes/no), its severity (mild, moderate, severe) and whether it was caused by the medication (yes/no). Data below represents a count of individual adverse effects reported on the SAFTEE during the alcohol infusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ivermectin Pharmacokinetics: Peak Concentration (Cmax)</measure>
    <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
    <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Maximum plasma concentration (Cmax), measured in ng/mL, provided below.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ivermectin Pharmacokinetics: Time to Cmax (Tmax)</measure>
    <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
    <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Time to Cmax (Tmax), measured in hours, provided below.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ivermectin Pharmacokinetics: Area Under the Time-concentration Curve (AUC)</measure>
    <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
    <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Area under the time-concentration curve (AUC) from 0 to 48 hours after IVM administration, provided below.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ivermectin Pharmacokinetics: Half-life (T1/2)</measure>
    <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
    <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Half-life of ivermectin (T1/2), measured in hours, provided below.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress-induced Alcohol Craving</measure>
    <time_frame>pre-post exposure to an imaginal stress script</time_frame>
    <description>Alcohol Urge Questionnaire (AUQ)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>Ivermectin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ivermectin 30 mg single dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matched placebo, single dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivermectin</intervention_name>
    <description>Ivermectin is a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum antiparasitic avermectin.</description>
    <arm_group_label>Ivermectin</arm_group_label>
    <other_name>Stromectol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matched placebo</description>
    <arm_group_label>Sugar pill</arm_group_label>
    <other_name>Sugar pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alcohol</intervention_name>
    <arm_group_label>Ivermectin</arm_group_label>
    <arm_group_label>Sugar pill</arm_group_label>
    <other_name>5% ethanol IV solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 21 and 65;

          -  meet current DSM-V diagnostic criteria for an alcohol use disorder

        Exclusion Criteria:

          -  current treatment for alcohol problems, a history of treatment in the 30 days before
             enrollment or current treatment seeking;

          -  a current (last 12 months) DSM-V diagnosis of dependence on any psychoactive
             substances other than alcohol and nicotine;

          -  a lifetime DSM-IV diagnosis of schizophrenia, bipolar disorder, or any psychotic
             disorder;

          -  positive urine screen for narcotics, amphetamines, or sedative hypnotics;

          -  serious alcohol withdrawal symptoms as indicated by a score ≥ 10 on the Clinical
             Institute Withdrawal Assessment for Alcohol-Revised (CIWA-R);

          -  pregnancy, nursing, or refusal to use reliable method of birth control (if female);

          -  a medical condition that may interfere with safe study participation (e.g., unstable
             cardiac, renal, or liver disease, uncontrolled hypertension or diabetes);

          -  AST, ALT, or GGT ≥ 3 times upper normal limit;

          -  currently on prescription medication that contraindicates use of IVN;

          -  any other circumstances that, in the opinion of the investigators, compromises
             participant safety.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lara Ray, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Roche, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Addictions Laboratory</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://addictions.psych.ucla.edu</url>
    <description>UCLA Addictions Laboratory</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2014</study_first_submitted>
  <study_first_submitted_qc>January 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2014</study_first_posted>
  <results_first_submitted>November 3, 2016</results_first_submitted>
  <results_first_submitted_qc>March 1, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 13, 2017</results_first_posted>
  <last_update_submitted>March 1, 2017</last_update_submitted>
  <last_update_submitted_qc>March 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Lara Ray</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>ivermectin, alcoholism, alcohol use disorder, treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Ivermectin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IVM 30mg First, Then Placebo</title>
          <description>First Intervention, Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.
Second Intervention, Placebo: Single dose sugar pill, matched to active medication.</description>
        </group>
        <group group_id="P2">
          <title>Placebo First, Then IVM 30 mg</title>
          <description>First Intervention, Placebo: Single dose sugar pill, matched to active medication.
Second Intervention, Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IVM 30mg; Placebo</title>
          <description>Ivermectin (IVM): Single dose (30 mg) of a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.
Placebo: Single dose sugar pill matched to active medication.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.82" spread="11.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Meets criteria for DSM-V AD</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Heart Rate</title>
        <description>Heart rate (measured in beats per minute; BPM) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
During the infusion, the times for collecting HR will vary based on how long it takes participants to reach the targeted BrACs.</description>
        <time_frame>Post-medication administration (hours): 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48; During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>Heart rate (measured in beats per minute; BPM) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
During the infusion, the times for collecting HR will vary based on how long it takes participants to reach the targeted BrACs.</description>
          <population>All randomized subjects included.</population>
          <units>BPM</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.57" spread="9.74"/>
                    <measurement group_id="O2" value="68.36" spread="20.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.5 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.82" spread="10.91"/>
                    <measurement group_id="O2" value="62.82" spread="11.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.09" spread="12.01"/>
                    <measurement group_id="O2" value="64.27" spread="11.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.18" spread="13.88"/>
                    <measurement group_id="O2" value="61.18" spread="11.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.73" spread="10.60"/>
                    <measurement group_id="O2" value="61.55" spread="12.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.27" spread="12.66"/>
                    <measurement group_id="O2" value="59.73" spread="12.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.36" spread="13.44"/>
                    <measurement group_id="O2" value="62.18" spread="11.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.70" spread="14.33"/>
                    <measurement group_id="O2" value="62.64" spread="10.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.45" spread="13.41"/>
                    <measurement group_id="O2" value="73.64" spread="9.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.18" spread="12.08"/>
                    <measurement group_id="O2" value="58.09" spread="10.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.55" spread="11.09"/>
                    <measurement group_id="O2" value="64.64" spread="10.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.18" spread="10.15"/>
                    <measurement group_id="O2" value="69.45" spread="12.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.09" spread="12.69"/>
                    <measurement group_id="O2" value="61.00" spread="11.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.27" spread="14.00"/>
                    <measurement group_id="O2" value="63.36" spread="9.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.91" spread="10.89"/>
                    <measurement group_id="O2" value="61.82" spread="9.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.64" spread="12.83"/>
                    <measurement group_id="O2" value="63.09" spread="9.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.36" spread="12.37"/>
                    <measurement group_id="O2" value="61.27" spread="8.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0563</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Systolic Blood Pressure</title>
        <description>Blood pressure (measured in mmHg) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
Blood pressure is measured at 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48 hours post-medication administration; and during alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl. During the infusion, the times for collecting BP will vary based on how long it takes participants to reach the targeted BrACs.</description>
        <time_frame>Post-medication administration (hours): 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48; During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>Blood pressure (measured in mmHg) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
Blood pressure is measured at 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48 hours post-medication administration; and during alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl. During the infusion, the times for collecting BP will vary based on how long it takes participants to reach the targeted BrACs.</description>
          <population>All randomized subjects included.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121" spread="11.10"/>
                    <measurement group_id="O2" value="111.64" spread="17.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.5 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.64" spread="10.67"/>
                    <measurement group_id="O2" value="117" spread="12.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.64" spread="11.44"/>
                    <measurement group_id="O2" value="116.27" spread="11.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.27" spread="10.59"/>
                    <measurement group_id="O2" value="118.27" spread="12.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117" spread="12.15"/>
                    <measurement group_id="O2" value="111.91" spread="12.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117.27" spread="16.17"/>
                    <measurement group_id="O2" value="119.55" spread="15.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.18" spread="13.50"/>
                    <measurement group_id="O2" value="107.27" spread="10.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.70" spread="13.49"/>
                    <measurement group_id="O2" value="114.09" spread="13.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.09" spread="9.17"/>
                    <measurement group_id="O2" value="119.63" spread="7.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.64" spread="17.19"/>
                    <measurement group_id="O2" value="115.45" spread="8.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122" spread="11.61"/>
                    <measurement group_id="O2" value="122.73" spread="8.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.72" spread="8.67"/>
                    <measurement group_id="O2" value="121.09" spread="9.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.27" spread="15.07"/>
                    <measurement group_id="O2" value="114.36" spread="12.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.55" spread="10.56"/>
                    <measurement group_id="O2" value="114.18" spread="12.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.55" spread="12.36"/>
                    <measurement group_id="O2" value="111.27" spread="10.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112.73" spread="11.40"/>
                    <measurement group_id="O2" value="115.18" spread="14.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112.45" spread="12.60"/>
                    <measurement group_id="O2" value="108.82" spread="11.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0342</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Diastolic Blood Pressure</title>
        <description>Blood pressure (measured in mmHg) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
Blood pressure is measured at 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48 hours post-medication administration; and during alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl. During the infusion, the times for collecting BP will vary based on how long it takes participants to reach the targeted BrACs.</description>
        <time_frame>Post-medication administration (hours): 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48; During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <description>Blood pressure (measured in mmHg) will be monitored to determine the safety of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl).
Blood pressure is measured at 0, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 48 hours post-medication administration; and during alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl. During the infusion, the times for collecting BP will vary based on how long it takes participants to reach the targeted BrACs.</description>
          <population>All randomized subjects included.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.64" spread="10.23"/>
                    <measurement group_id="O2" value="75.55" spread="13.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.5 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.45" spread="11.44"/>
                    <measurement group_id="O2" value="75.18" spread="11.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.82" spread="10.30"/>
                    <measurement group_id="O2" value="74.91" spread="10.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.91" spread="8.80"/>
                    <measurement group_id="O2" value="76.64" spread="12.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.55" spread="10.82"/>
                    <measurement group_id="O2" value="72.18" spread="10.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.36" spread="14.49"/>
                    <measurement group_id="O2" value="74.55" spread="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.55" spread="10.05"/>
                    <measurement group_id="O2" value="69.45" spread="10.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.30" spread="11.88"/>
                    <measurement group_id="O2" value="73.82" spread="12.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.64" spread="9.84"/>
                    <measurement group_id="O2" value="77.27" spread="6.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.82" spread="12.69"/>
                    <measurement group_id="O2" value="73.18" spread="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.09" spread="12.39"/>
                    <measurement group_id="O2" value="78.09" spread="10.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours post-med</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.55" spread="10.96"/>
                    <measurement group_id="O2" value="81.55" spread="10.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.18" spread="11.57"/>
                    <measurement group_id="O2" value="74.36" spread="12.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.91" spread="10.01"/>
                    <measurement group_id="O2" value="73.73" spread="10.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.55" spread="10.71"/>
                    <measurement group_id="O2" value="72.91" spread="11.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.27" spread="9.31"/>
                    <measurement group_id="O2" value="74.00" spread="12.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.91" spread="10.90"/>
                    <measurement group_id="O2" value="72.73" spread="10.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1597</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Alcohol Urge Questionnaire (AUQ)</title>
        <description>Subjective effects of alcohol will be measured using the Alcohol Urge Questionnaire (AUQ), which consists of 8 items associated with urge to drink alcohol, rated on a 7 point scale (1 = strongly disagree, 7 = strongly agree).</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Alcohol Urge Questionnaire (AUQ)</title>
          <description>Subjective effects of alcohol will be measured using the Alcohol Urge Questionnaire (AUQ), which consists of 8 items associated with urge to drink alcohol, rated on a 7 point scale (1 = strongly disagree, 7 = strongly agree).</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" spread="1.74"/>
                    <measurement group_id="O2" value="2.90" spread="2.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.14" spread="1.64"/>
                    <measurement group_id="O2" value="3.27" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.02" spread="1.64"/>
                    <measurement group_id="O2" value="3.19" spread="1.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.73" spread="2.00"/>
                    <measurement group_id="O2" value="2.60" spread="1.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" spread="1.79"/>
                    <measurement group_id="O2" value="2.91" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.7617</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;Feel&quot; Subscale</title>
        <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Do you feel any drug effects?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;Feel&quot; Subscale</title>
          <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Do you feel any drug effects?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.36" spread="2.66"/>
                    <measurement group_id="O2" value="0.91" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.73" spread="2.45"/>
                    <measurement group_id="O2" value="3.45" spread="2.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.82" spread="2.75"/>
                    <measurement group_id="O2" value="4.82" spread="3.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.45" spread="3.48"/>
                    <measurement group_id="O2" value="5.36" spread="3.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.27" spread="3.29"/>
                    <measurement group_id="O2" value="6.36" spread="2.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.93</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;Like&quot; Subscale</title>
        <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Do you like the effects you are feeling right now?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;Like&quot; Subscale</title>
          <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Do you like the effects you are feeling right now?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.09" spread="1.70"/>
                    <measurement group_id="O2" value="4.09" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.36" spread="1.63"/>
                    <measurement group_id="O2" value="5.36" spread="3.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.18" spread="2.52"/>
                    <measurement group_id="O2" value="5.55" spread="2.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.64" spread="2.98"/>
                    <measurement group_id="O2" value="6.36" spread="3.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.45" spread="3.33"/>
                    <measurement group_id="O2" value="6.27" spread="3.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.95</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;More&quot; Subscale</title>
        <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Would you like more of the drug right now?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;More&quot; Subscale</title>
          <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Would you like more of the drug right now?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" spread="2.25"/>
                    <measurement group_id="O2" value="3.18" spread="4.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.91" spread="4.09"/>
                    <measurement group_id="O2" value="6.27" spread="4.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.45" spread="3.96"/>
                    <measurement group_id="O2" value="6.00" spread="3.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.00" spread="3.92"/>
                    <measurement group_id="O2" value="5.64" spread="4.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.27" spread="4.25"/>
                    <measurement group_id="O2" value="5.55" spread="4.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.43</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;High&quot; Subscale</title>
        <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Are you high?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Drug Effects Questionnaire (DEQ) - &quot;High&quot; Subscale</title>
          <description>Subjective effects of alcohol will be measured using the Drug Effects Questionnaire, which consists of 4 items that capture subjective effects, (feeling effects, liking effects, wanting more and being high). The question &quot;Are you high?&quot; was rated on an 11 point scale from 0 to 10 (higher values represent more effects).</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" spread="1.70"/>
                    <measurement group_id="O2" value="0.09" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.64" spread="2.29"/>
                    <measurement group_id="O2" value="3.27" spread="2.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.00" spread="2.93"/>
                    <measurement group_id="O2" value="5.36" spread="2.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.91" spread="3.56"/>
                    <measurement group_id="O2" value="5.73" spread="2.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.09" spread="3.62"/>
                    <measurement group_id="O2" value="6.00" spread="2.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.06</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Biphasic Alcohol Effects Scale (BAES) - Stimulant Subscale</title>
        <description>Subjective effects of alcohol will be measured using the Biphasic Alcohol Effects Scale (BAES) , which consists of 14 items designed to capture the stimulant and sedative effects of alcohol, each rated on an 11-point scale (0 = not at all, 10 = extremely). The total score for the Stimulant Subscale ranges from 0 to 70. Mean scores across all subjects are reported below.</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Biphasic Alcohol Effects Scale (BAES) - Stimulant Subscale</title>
          <description>Subjective effects of alcohol will be measured using the Biphasic Alcohol Effects Scale (BAES) , which consists of 14 items designed to capture the stimulant and sedative effects of alcohol, each rated on an 11-point scale (0 = not at all, 10 = extremely). The total score for the Stimulant Subscale ranges from 0 to 70. Mean scores across all subjects are reported below.</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.09" spread="13.37"/>
                    <measurement group_id="O2" value="17.36" spread="12.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.00" spread="11.91"/>
                    <measurement group_id="O2" value="23.73" spread="14.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.73" spread="15.04"/>
                    <measurement group_id="O2" value="20.09" spread="13.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.91" spread="19.03"/>
                    <measurement group_id="O2" value="22.64" spread="15.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.18" spread="20.17"/>
                    <measurement group_id="O2" value="20.91" spread="15.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.21</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects of Alcohol Using the Biphasic Alcohol Effects Scale (BAES) - Sedative Subscale</title>
        <description>Subjective effects of alcohol will be measured using the Biphasic Alcohol Effects Scale (BAES) , which consists of 14 items designed to capture the stimulant and sedative effects of alcohol, each rated on an 11-point scale (0 = not at all, 10 = extremely). The total score for the Sedative Subscale ranges from 0 to 70. Mean scores across subjects are reported below.</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.02, 0.04, 0.06, 0.08 g/dl period; which is expected to last approximately 6 hours.</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of Alcohol Using the Biphasic Alcohol Effects Scale (BAES) - Sedative Subscale</title>
          <description>Subjective effects of alcohol will be measured using the Biphasic Alcohol Effects Scale (BAES) , which consists of 14 items designed to capture the stimulant and sedative effects of alcohol, each rated on an 11-point scale (0 = not at all, 10 = extremely). The total score for the Sedative Subscale ranges from 0 to 70. Mean scores across subjects are reported below.</description>
          <population>All randomized subjects included.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BrAC = 0.00</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.18" spread="14.67"/>
                    <measurement group_id="O2" value="10.64" spread="9.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.02</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.00" spread="13.10"/>
                    <measurement group_id="O2" value="13.09" spread="14.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.91" spread="14.72"/>
                    <measurement group_id="O2" value="16.00" spread="15.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.06</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.27" spread="17.41"/>
                    <measurement group_id="O2" value="16.73" spread="19.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BrAC = 0.08</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.27" spread="18.93"/>
                    <measurement group_id="O2" value="16.64" spread="17.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.09</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cue-induced Craving Using the Alcohol Urge Questionnaire (AUQ)</title>
        <description>Cue-induced craving will be measured using the Alcohol Urge Questionnaire (AUQ), which consists of 8 items associated with urge to drink alcohol, rated on a 7 point scale (0 = strongly disagree, 6 = strongly agree). Item scores were averaged and the total score also ranges from 0-6.</description>
        <time_frame>6 hours post-medication administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Cue-induced Craving Using the Alcohol Urge Questionnaire (AUQ)</title>
          <description>Cue-induced craving will be measured using the Alcohol Urge Questionnaire (AUQ), which consists of 8 items associated with urge to drink alcohol, rated on a 7 point scale (0 = strongly disagree, 6 = strongly agree). Item scores were averaged and the total score also ranges from 0-6.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.59" spread="1.69"/>
                    <measurement group_id="O2" value="4.07" spread="1.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.99</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Adverse Effects</title>
        <description>Adverse effects will be monitored to determine the safe of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl) using the Systematic Assessment for Treatment Emergent Effects (SAFTEE). The SAFTEE is a 24-item checklist in which the participant can identify whether a symptom is present (yes/no), its severity (mild, moderate, severe) and whether it was caused by the medication (yes/no). Data below represents a count of individual adverse effects reported on the SAFTEE during the alcohol infusion.</description>
        <time_frame>During alcohol infusion at BrAC = 0.00, 0.04, 0.08 g/dl</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (BrAC = 0.00)</title>
            <description>Single dose sugar pill, matched to active medication. Timepoint is at beginning of alcohol infusion when BrAC is still 0.00.</description>
          </group>
          <group group_id="O2">
            <title>Placebo (BrAC = 0.04)</title>
            <description>Single dose sugar pill, matched to active medication. Timepoint is during alcohol infusion when BrAC has reached 0.04.</description>
          </group>
          <group group_id="O3">
            <title>Placebo (BrAC = 0.08)</title>
            <description>Single dose sugar pill, matched to active medication. Timepoint is during alcohol infusion when BrAC has reached 0.08.</description>
          </group>
          <group group_id="O4">
            <title>IVM 30mg (BrAC = 0.00)</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin. Timepoint is at beginning of alcohol infusion when BrAC is still 0.00.</description>
          </group>
          <group group_id="O5">
            <title>IVM 30mg (BrAC = 0.04)</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin. Timepoint is during alcohol infusion when BrAC has reached 0.04.</description>
          </group>
          <group group_id="O6">
            <title>IVM 30mg (BrAC = 0.08)</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin. Timepoint is during alcohol infusion when BrAC has reached 0.08.</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Effects</title>
          <description>Adverse effects will be monitored to determine the safe of combining IVM (30 mg) with moderate doses of alcohol (0.08 g/dl) using the Systematic Assessment for Treatment Emergent Effects (SAFTEE). The SAFTEE is a 24-item checklist in which the participant can identify whether a symptom is present (yes/no), its severity (mild, moderate, severe) and whether it was caused by the medication (yes/no). Data below represents a count of individual adverse effects reported on the SAFTEE during the alcohol infusion.</description>
          <population>All randomized subjects included.</population>
          <units>adverse effect count</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Abdominal pain/cramps</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yellow eyes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea or vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritability or anger</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Increased desire for sex</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nervousness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ringing in the ears</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decrease in appetite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficulty in staying awake</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Increase in appetite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blurred vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drowsiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Night sweats</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental confusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint or muscle pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dizziness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sexual problems</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficulty sleeping</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever or chills</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased desire for sex</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ivermectin Pharmacokinetics: Peak Concentration (Cmax)</title>
        <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Maximum plasma concentration (Cmax), measured in ng/mL, provided below.</description>
        <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Ivermectin Pharmacokinetics: Peak Concentration (Cmax)</title>
          <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Maximum plasma concentration (Cmax), measured in ng/mL, provided below.</description>
          <population>All randomized subjects included.</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="406.03" spread="398.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ivermectin Pharmacokinetics: Time to Cmax (Tmax)</title>
        <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Time to Cmax (Tmax), measured in hours, provided below.</description>
        <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Ivermectin Pharmacokinetics: Time to Cmax (Tmax)</title>
          <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Time to Cmax (Tmax), measured in hours, provided below.</description>
          <population>All randomized subjects included.</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.09" spread="3.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ivermectin Pharmacokinetics: Area Under the Time-concentration Curve (AUC)</title>
        <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Area under the time-concentration curve (AUC) from 0 to 48 hours after IVM administration, provided below.</description>
        <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
        <population>All randomized subjects included.</population>
        <group_list>
          <group group_id="O1">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Ivermectin Pharmacokinetics: Area Under the Time-concentration Curve (AUC)</title>
          <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Area under the time-concentration curve (AUC) from 0 to 48 hours after IVM administration, provided below.</description>
          <population>All randomized subjects included.</population>
          <units>ng*h/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5078" spread="4258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ivermectin Pharmacokinetics: Half-life (T1/2)</title>
        <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Half-life of ivermectin (T1/2), measured in hours, provided below.</description>
        <time_frame>Hours post-drug administration: 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 16, 24, 48</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Ivermectin Pharmacokinetics: Half-life (T1/2)</title>
          <description>This study will collect blood samples for pharmacokinetic (PK) and pharmacodynamic profiling in order to examine whether IVM metabolism corresponds to its effects on alcohol response. Half-life of ivermectin (T1/2), measured in hours, provided below.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.75" spread="6.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stress-induced Alcohol Craving</title>
        <description>Alcohol Urge Questionnaire (AUQ)</description>
        <time_frame>pre-post exposure to an imaginal stress script</time_frame>
        <population>The stress paradigm (pre-post exposure to an imaginal stress script) was not implemented from the outset of the study due to feasibility reasons. In particular, the investigators were concerned that the timing of the stress exposure might contaminate the effects of the alcohol administration.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Single dose sugar pill, matched to active medication.</description>
          </group>
          <group group_id="O2">
            <title>IVM 30mg</title>
            <description>Ivermectin (IVM): Single dose (30 mg) of semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum anti parasitic avermectin.</description>
          </group>
        </group_list>
        <measure>
          <title>Stress-induced Alcohol Craving</title>
          <description>Alcohol Urge Questionnaire (AUQ)</description>
          <population>The stress paradigm (pre-post exposure to an imaginal stress script) was not implemented from the outset of the study due to feasibility reasons. In particular, the investigators were concerned that the timing of the stress exposure might contaminate the effects of the alcohol administration.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>IVM 30mg</title>
          <description>Ivermectin 30 mg single dose
Ivermectin: Ivermectin is a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum antiparasitic avermectin.
Alcohol</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Matched placebo, single dose
Placebo: sugar pill
Alcohol</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lara Ray</name_or_title>
      <organization>UCLA Department of Psychology</organization>
      <phone>310-794-5383</phone>
      <email>lararay@psych.ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

